Orthocell Limited (ASX:OCC)
Australia flag Australia · Delayed Price · Currency is AUD
0.8200
-0.0100 (-1.20%)
Mar 11, 2026, 4:10 PM AEST

Orthocell Income Statement

Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
9.337.555.324.241.531.02
Revenue Growth (YoY)
23.65%42.05%25.27%177.01%50.47%41.48%
Cost of Revenue
3.382.751.631.030.70.63
Gross Profit
5.954.83.693.220.830.39
Selling, General & Admin
12.639.416.75.965.544.72
Research & Development
9.228.828.677.66.827.34
Other Operating Expenses
-0.36-0.36-0.42-0.06-0-0.04
Operating Expenses
22.717.8814.9513.512.3512.02
Operating Income
-16.75-13.07-11.26-10.28-11.52-11.63
Interest & Investment Income
1.541.31.030.850.080.2
Currency Exchange Gain (Loss)
-0.240.02-0.020.190
EBT Excluding Unusual Items
-15.67-11.75-10.23-9.41-11.25-11.43
Pretax Income
-15.67-11.75-10.23-9.41-11.25-11.43
Income Tax Expense
-3.19-3.19-3.05-3.16-2.14-2.39
Net Income
-12.48-8.57-7.18-6.25-9.11-9.04
Net Income to Common
-12.48-8.57-7.18-6.25-9.11-9.04
Shares Outstanding (Basic)
239223202197195187
Shares Outstanding (Diluted)
239223202197195187
Shares Change (YoY)
14.29%10.52%2.43%1.31%4.18%9.27%
EPS (Basic)
-0.05-0.04-0.04-0.03-0.05-0.05
EPS (Diluted)
-0.05-0.04-0.04-0.03-0.05-0.05
Free Cash Flow
-12.21-8.94-7.4313.98-6.78-4.67
Free Cash Flow Per Share
-0.05-0.04-0.040.07-0.04-0.03
Gross Margin
63.77%63.63%69.39%75.82%54.13%38.54%
Operating Margin
-179.49%-173.12%-211.92%-242.28%-752.21%-1142.59%
Profit Margin
-133.78%-113.45%-135.10%-147.26%-594.53%-887.76%
Free Cash Flow Margin
-130.85%-118.44%-139.82%329.46%-442.55%-458.83%
EBITDA
-16.45-12.7-10.91-9.93-11.3-11.3
EBITDA Margin
-176.30%-168.14%-205.25%-233.91%--
D&A For EBITDA
0.30.380.350.350.220.34
EBIT
-16.75-13.07-11.26-10.28-11.52-11.63
EBIT Margin
-179.49%-173.12%-211.92%-242.28%--
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.